Israel's Taro Pharmaceutical Industries Ltd. is in talks to be bought out by Hungary's leading drug company Richter Gedeon Nyrt, Reuters cited the Yedioth Ahronoth daily as reporting on Sunday. Yedioth said Taro had asked Merril Lynch to find a buyer, and that Richter, with a market cap of around $ 4 billion, is the more likely of two potential Hungarian buyers. Reuters said it could not reach Taro officials for comment. "Buying Taro would not boost Richter's standing in the profitable CIS and CEE markets (90% of sales are in North America) and so dilute the value of the franchise," Bram Buring of Wood & Co. has commented on Monday. The market capitalisation of Taro is $ 400 million. The consensus of five analysts indicates $ 295 million revenues and $ 17.5 million for Taro for this year. Based on analysts' expectations Taro's PE-based pricing is 22.6 for 2006 and 18.3 for next year. (Portfolio.hu)
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.